Tonix Pharmaceuticals Holding Corp (TNXP)
EBITDA Margin
-294.84%
Quarterly · Period ending:
TNXP EBITDA Margin
Latest reported-294.84%period ending
Latest reported-294.84%period ending
TNXP Quarterly EBITDA Margin (0.00% → -294.84%)
Quarterly ebitda margin
High-resolution chart · PNG
TNXP ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -294.839% | |
| -576.3158% | |
| -861.2616% | |
| -958.9361% | |
| -1,390.8408% | |
| -672.5401% | |
| -837.0256% | |
| -485.5776% | |
| -3,513.1793% | |
| -553.1426% | |
| -689.6269% | |
| -670.8198% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 1,745,800% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |